Market Overview - On May 23, the total trading volume of stocks on the Beijing Stock Exchange reached 1.269 billion shares, with a total transaction value of 27.181 billion yuan, a decrease of 10.005 billion yuan compared to the previous trading day [1] - Among the tradable stocks, 57 stocks closed higher, accounting for 21.43% of the total, with notable gainers including Chenguang Medical, Changfu Co., and Senxuan Pharmaceutical, which rose by 14.96%, 10.12%, and 9.73% respectively [1] - Conversely, 208 stocks closed lower, with the largest declines seen in Kexin New Materials, Shengnan Technology, and Air China Ocean, which fell by 9.04%, 8.54%, and 7.89% respectively [1] Trading Activity - A total of 87 stocks had transaction values exceeding 10 million yuan, with the highest transaction values recorded for Jinbo Biological, Changfu Co., and Wuxin Tunnel Equipment, at 813 million yuan, 597 million yuan, and 517 million yuan respectively [1] - In terms of trading activity, 48 stocks had a turnover rate exceeding 10%, with 8 stocks exceeding 20%. Additionally, 94 stocks had turnover rates between 5% and 10%, while 122 stocks had turnover rates between 1% and 5% [1] - The stocks with the highest turnover rates included Ningxin New Materials, Chenguang Medical, and Changfu Co., with turnover rates of 33.42%, 32.11%, and 31.21% respectively [1] Stock Performance - The closing prices and performance of notable stocks included: - Jinbo Biological: Closing price of 497.70 yuan, up 0.85%, turnover rate of 3.54%, transaction value of 812.56 million yuan [1] - Changfu Co.: Closing price of 45.90 yuan, up 10.12%, turnover rate of 31.21%, transaction value of 597.47 million yuan [1] - Wuxin Tunnel Equipment: Closing price of 41.27 yuan, down 7.28%, turnover rate of 14.02%, transaction value of 516.61 million yuan [1] - Chenguang Medical: Closing price of 21.90 yuan, up 14.96%, turnover rate of 32.11%, transaction value of 473.16 million yuan [1] - Air China Ocean: Closing price of 10.04 yuan, down 7.89%, turnover rate of 15.90%, transaction value of 473.14 million yuan [1]

Group 1: Investor Relations Activities - The company held an earnings briefing on May 21, 2025, from 15:00 to 17:00 via the "Investor Relations Interactive Platform" [3] - Participants included the company's chairman, general manager, and other key executives [3] Group 2: Financial Performance - The company raised a total of 32.84 million RMB during its IPO and has distributed dividends totaling 57.83 million RMB over five occasions [4][5] - In Q1 2025, the company reported revenue of 46.05 million RMB, a decrease of 21.31% year-on-year, and a net profit of 5.87 million RMB, down 23.23% year-on-year [7] Group 3: Future Plans and Projects - The company has no current plans for mergers or acquisitions but maintains a strong cash flow and financial position [5] - A new factory project, covering 79 acres with a total construction area of 70,332.60 square meters, is set to be completed by June 30, 2025, with a total investment of 115.88 million RMB [6] Group 4: Product Innovation and Market Strategy - The company focuses on technological innovation and product upgrades, particularly in nuclear energy systems, to meet specific market demands [5] - The company aims to enhance its core competitiveness and expand its market presence through new factory construction and automation [5] Group 5: Accounts Receivable Management - As of December 31, 2024, accounts receivable amounted to 84.21 million RMB, representing 33.04% of total revenue, with a slight decrease of 2.93% from the previous year [8] - The company employs various methods to assess credit risk and has implemented measures to optimize accounts receivable management, ensuring a low risk of bad debts [8]

Core Viewpoint - The recent surge in stock prices of companies involved in controlled nuclear fusion, particularly Wangzi New Materials, is largely driven by market interest in the nuclear fusion concept and recent government approvals for nuclear power projects in China [2][4][6]. Company Summary - Wangzi New Materials (002735.SZ) experienced a significant stock increase, closing at 15.26 yuan per share, influenced by the nuclear fusion concept and its indirect involvement in a fusion energy project [2]. - The company has been in contact with clients for two to three years regarding technology integration for a project, providing customized capacitors as electronic components [2][5]. - Wangzi New Materials has seen a 61.65% increase in stock price this month, becoming a leader in the nuclear fusion concept stocks [4]. Industry Summary - The controlled nuclear fusion index has risen from 1189.1 to 1453 since April 9, marking a 22.19% increase, outpacing the broader market indices [4]. - The Chinese government has approved multiple nuclear power projects, including five new nuclear power units, which is expected to enhance the focus on nuclear energy development in the country [5][6]. - China's nuclear power generation capacity is projected to grow significantly, with expectations of reaching 400 million kilowatts by 2035, which would align with global averages [6][8]. - The nuclear fusion sector is anticipated to attract substantial investment, with estimates suggesting that the total investment in domestic experimental reactors could exceed 60 billion yuan [7][9]. - Despite the enthusiasm, nuclear fusion remains a long-term goal, with significant challenges in commercialization and cost competitiveness compared to renewable energy sources [8][9].

Market Overview - On May 20, the total trading volume of stocks on the Beijing Stock Exchange reached 1.975 billion shares, with a total transaction value of 41.723 billion yuan, an increase of 9.135 billion yuan compared to the previous trading day [1] - Among the tradable stocks, 237 stocks closed higher, accounting for 89.10% of the total, while 29 stocks closed lower [1] Stock Performance - The stocks with the highest closing price increases included Xujie Technology, Lusi Co., and Donghe New Materials, which rose by 19.66%, 18.10%, and 14.48% respectively [1] - Conversely, the stocks with the largest declines were Guohang Ocean, Qifeng Precision, and Changfu Co., which fell by 17.92%, 15.25%, and 8.89% respectively [1] Trading Activity - A total of 145 stocks had transaction values exceeding 10 million yuan, with Guohang Ocean, Wuxin Tunnel Equipment, and Lusi Co. leading at 1.138 billion yuan, 985.37 million yuan, and 770.12 million yuan respectively [1] - The trading activity was notably high, with 101 stocks having a turnover rate exceeding 10%, and 30 stocks exceeding 20% [1] Notable Stocks - Guohang Ocean closed at 11.04 yuan with a decline of 17.92% and a turnover rate of 34.58% [1] - Wuxin Tunnel Equipment closed at 55.69 yuan with a significant increase of 30.00% and a turnover rate of 22.17% [1] - Lusi Co. closed at 31.78 yuan, up by 18.10% with a turnover rate of 26.01% [1]

5月19日，北交所个股合计成交量15.42亿股，成交额325.88亿元，成交额相对上一交易日减少20.96亿 元，个股来看，收盘上涨的共166只。 | 831961 | 创远信科 | 23.40 | 5.64 | 12.41 | 30152.90 | | --- | --- | --- | --- | --- | --- | | 837242 | 建邦科技 | 37.76 | -2.55 | 19.08 | 27420.76 | | 920029 | 开发科技 | 107.10 | 2.54 | 8.12 | 27318.15 | | 832876 | 慧为智能 | 37.36 | -6.60 | 17.94 | 26292.62 | | 834599 | 同力股份 | 22.58 | 5.81 | 3.43 | 26057.63 | | 832171 | 志晟信息 | 30.39 | 2.12 | 12.58 | 25041.75 | | 838971 | 天马新材 | 33.35 | 6.55 | 9.14 | 25033.59 | | 873576 | 天力复合 | 36.75 | 2.65 | 6.3 ...

证券代码：871396 证券简称：常辅股份 公告编号：2025-046 常州电站辅机股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 5 月 15 日至 2025 年 5 月 16 日 活动地点：常州电站辅机股份有限公司会议室 √特定对象调研 □业绩说明会 参会单位及人员：中信证券股份有限公司、平安基金管理有限公司、陕西趋 势投资管理有限公司、西部证券股份有限公司、铁林（厦门）股权投资私募基金 管理有限公司、江海证券有限公司 1、公司 ZE、QF 等新产品 2024 年已进入市场推广阶段，取得了较好的销 售业绩，2025 年销售部门要加大 ZE、QF 系列产品的市场推广力度，提升公司 产品在市场上的竞争能力。 2、狠抓新品开发，通过围绕客户需求进行分析研判，更好的满足客户需 求，着重致力于产品高端化延伸、应用领域多维度扩展、 ...

Group 1: Financial Performance - The company's Q1 2025 revenue decreased by 21.31% compared to the same period last year, with ordinary and intelligent products revenue at 29.93 million CNY, down 11.52% [4] - Nuclear product revenue was 14.14 million CNY, a decline of 37.92% year-on-year, attributed to a decrease in project orders and delivery schedules [4] Group 2: Revenue Trends - Revenue for ordinary and intelligent products from 2022 to 2024 was 172.39 million CNY, 159.46 million CNY, and 168.40 million CNY respectively, showing a 5.61% increase in 2024 compared to 2023, but a 2.31% decrease from 2022 [5] - The company aims to enhance revenue through new product launches and market strategies [5][6] Group 3: Nuclear Product Development - The company has been involved in the civil nuclear power sector since the 1980s, developing various nuclear-grade valve actuators [8] - Future plans include addressing specific application environments in nuclear power, such as sodium fire and high magnetic fields, to meet the demand for miniaturization and intelligent operation [9] Group 4: Market Share and Opportunities - The company holds a significant market share in the nuclear sector, benefiting from early certifications and product development [10] - Five new nuclear projects were approved in April 2025, which are expected to increase the company's nuclear product orders [11] Group 5: Industry Outlook - Nuclear energy is a strategic choice for achieving carbon neutrality in China, with projections indicating that by 2035, nuclear power generation could account for approximately 10% of the energy mix [13] - The nuclear power sector is expected to expand, contributing to economic growth and technological advancements [13]

证券代码：871396 证券简称：常辅股份 公告编号：2025-044 常州电站辅机股份有限公司 关于使用自有闲置资金购买理财产品的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、 授权自有资金购买理财产品情况 （一）购买理财产品的审议情况 为了进一步提高自有资金使用效率，提升收益水平，为公司股东谋取更多 的利益回报，公司于 2025 年 4 月 18 日召开第三届董事会第十八次会议， 审议通过《关于使用闲置自有资金购买理财产品的议案》，在不影响公司的日 常生产经营资金使用和保证日常流动资金需求的前提下，公司拟使用不超过 5,000 万元（含 5,000 万元）闲置自有资金购买安全性高、流动性好的低风险 理财产品，在上述额度内资金可以循环滚动使用。购买理财产品期限为董事会 审议通过之日起一年内有效。 根据《北京证券交易所股票上市规则》的相关规定，上市公司以自有资金 实际购买理财产品，交易的成交金额占上市公司最近一期经审计净资产的 10% 以上，且超过 1,000 万元的应予以披露；上市公司 ...

Core Insights - As of April 25, the total margin financing and securities lending balance on the Beijing Stock Exchange (BSE) was 5.258 billion yuan, a decrease of 56.9734 million yuan from the previous trading day [1] - The top three stocks by margin financing balance were Jinbo Biological, Airon Software, and Better Ray, with balances of 204 million yuan, 145 million yuan, and 134 million yuan respectively [1] - The average margin financing balance as a percentage of market capitalization for these stocks was 1.18%, with the highest ratios for Pino Technology, Meideng Technology, and Guozi Software at 6.67%, 5.60%, and 4.17% respectively [1] Margin Financing Activity - On April 25, 99 stocks on the BSE had net margin purchases, with 26 stocks having net purchases exceeding 1 million yuan [2] - Changfu Co. led with a net purchase of 6.7713 million yuan, followed by Kaifa Technology and Xuchang Intelligent with net purchases of 6.4205 million yuan and 5.2924 million yuan respectively [2] - The stocks with the highest net margin sales included Jinbo Biological, Parallel Technology, and Zhuozhao Point Glue, with net sales of 16.7692 million yuan, 8.4805 million yuan, and 5.1862 million yuan respectively [2] Industry Performance - The industries with the most stocks receiving net margin purchases over 1 million yuan were machinery equipment, basic chemicals, and computers, with 5, 4, and 3 stocks respectively [2] - On average, stocks with net margin purchases over 1 million yuan saw a decline of 2.10% on April 25, with Bawei Co., Guozi Software, and Xuchang Intelligent showing increases of 9.03%, 3.36%, and 2.27% respectively [2] - The average turnover rate for stocks with net margin purchases over 1 million yuan was 5.18%, with the highest turnover rates for Kaibaier, Bawei Co., and Kaifa Technology at 35.50%, 33.85%, and 23.00% respectively [2] Notable Stocks - The stocks with the largest increases in margin financing balance on April 25 included Changfu Co. (increase of 6.7713 million yuan), Kaifa Technology (increase of 6.4205 million yuan), and Xuchang Intelligent (increase of 5.2924 million yuan) [3] - Other notable stocks with significant margin financing increases included New Ganjing, Dingzhi Technology, and Lusi Co. [3] - The stocks with the largest decreases in margin financing balance included Jinbo Biological, Parallel Technology, and Zhuozhao Point Glue [3]